NMRA laboratory lacks SLAB accreditation

"Setting up state-of-the-art drug testing facility will cost Rs 5 billion" Activists call for legal action against politicians, bureaucrats

- BY CHAMINDA SILVA

Serious questions have been raised over Sri Lanka's drug regulatory system following revelations that the National Medicines Regulatory Authority's (NMRA) quality control laboratory is not accredited by the Sri Lanka Accreditation Board (SLAB), casting doubt on both the reliability of local test results and the adequacy of oversight of imported medicines.

Medical and civil rights groups warn that the issue points to a systemic regulatory failure rather than an isolated lapse, with potential political and financial consequences for the State.

Chairman of the Federation of Medical and Civil Rights Professional Associations, Specialist Dr. Chamal Sanjeewa, said the controversy surrounding the Ondansetron injection, which was later found to be contaminated, had exposed deep weaknesses in drug regulation and quality assurance.